1. Home
  2. NEPH vs PRT Comparison

NEPH vs PRT Comparison

Compare NEPH & PRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEPH
  • PRT
  • Stock Information
  • Founded
  • NEPH 1997
  • PRT 2017
  • Country
  • NEPH United States
  • PRT United States
  • Employees
  • NEPH N/A
  • PRT N/A
  • Industry
  • NEPH Medical/Dental Instruments
  • PRT Oil & Gas Production
  • Sector
  • NEPH Health Care
  • PRT Energy
  • Exchange
  • NEPH Nasdaq
  • PRT Nasdaq
  • Market Cap
  • NEPH 57.2M
  • PRT 48.1M
  • IPO Year
  • NEPH 2004
  • PRT N/A
  • Fundamental
  • Price
  • NEPH $5.18
  • PRT $3.90
  • Analyst Decision
  • NEPH Strong Buy
  • PRT
  • Analyst Count
  • NEPH 2
  • PRT 0
  • Target Price
  • NEPH $5.50
  • PRT N/A
  • AVG Volume (30 Days)
  • NEPH 79.5K
  • PRT 28.1K
  • Earning Date
  • NEPH 11-05-2025
  • PRT 11-12-2025
  • Dividend Yield
  • NEPH N/A
  • PRT 10.80%
  • EPS Growth
  • NEPH N/A
  • PRT 1.16
  • EPS
  • NEPH 0.12
  • PRT 0.44
  • Revenue
  • NEPH $16,684,000.00
  • PRT $6,314,770.00
  • Revenue This Year
  • NEPH $24.38
  • PRT N/A
  • Revenue Next Year
  • NEPH $10.16
  • PRT N/A
  • P/E Ratio
  • NEPH $43.88
  • PRT $8.86
  • Revenue Growth
  • NEPH 21.16
  • PRT 1.82
  • 52 Week Low
  • NEPH $1.36
  • PRT $3.26
  • 52 Week High
  • NEPH $5.98
  • PRT $4.63
  • Technical
  • Relative Strength Index (RSI)
  • NEPH 54.89
  • PRT 47.36
  • Support Level
  • NEPH $4.52
  • PRT $3.85
  • Resistance Level
  • NEPH $5.38
  • PRT $3.98
  • Average True Range (ATR)
  • NEPH 0.48
  • PRT 0.06
  • MACD
  • NEPH -0.05
  • PRT -0.00
  • Stochastic Oscillator
  • NEPH 45.21
  • PRT 38.46

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.

About PRT PermRock Royalty Trust Trust Units

PermRock Royalty Trust operates as a statutory trust. Its purpose is to own the Net Profits Interest, to distribute to the Trust unitholders cash that it receives in respect of the Net Profits Interest, and to perform certain administrative functions. The Net Profits Interest entitles the trust to receive the net profits from the sale of oil and natural gas production from the underlying properties of its trustor.

Share on Social Networks: